Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.

PloS one - 1 Jan 2013

Ueda Youki, Takeda Midori, Mori Kyoko, Dansako Hiromichi, Wakita Takaji, Kim Hye-Sook, Sato Akira, Wataya Yusuke, Ikeda Masanori, Kato Nobuyuki

Abstract excerpt

BACKGROUND: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more than 70% in HCV genotype 1 patients, there are several problems to be resolved, including skin rash/ageusia and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Synergism

Share to Genome, Viral

Share to Interferon-alpha

Share to Ribavirin

Share to Virus Replication

Share to Vitamin E

Source

Open in PubMed Open full text

Identifiers

PMID: 24023620
DOI: 10.1371/journal.pone.0072519
PMCID: PMC3758303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.PMID 24023620Read ↗

Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.Semantic proximity Read ↗

Robust hepatitis C virus infection <i>in vitro</i>Semantic proximity Read ↗

Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052.Semantic proximity Read ↗

Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.Semantic proximity Read ↗

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations.Semantic proximity Read ↗

Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052.Semantic proximity Read ↗

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.Semantic proximity Read ↗

Nucleoside Analog Inhibitors of Hepatitis C Virus ReplicationSemantic proximity Read ↗

Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model.Semantic proximity Read ↗

Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.Semantic proximity Read ↗

Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.Semantic proximity Read ↗

Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.